Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122381 · ClinicalTrials.gov registry record · Phase 1
Comparison of a Drug and Placebo in the Prevention of Migraine Headaches
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01122381 is a Phase 1 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 5 participants.
The verdict
NCT01122381, a Phase 1 study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
Interventions
- OTHER placebo comparator
- DRUG ethosuximide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122381
The ClinicalTrials.gov registry entry for NCT01122381 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo comparator is the first listed.
NCT01122381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01122381 about?
NCT01122381 is a clinical study titled "Comparison of a Drug and Placebo in the Prevention of Migraine Headaches". The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
What is the current status of trial NCT01122381?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2011-12. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01122381?
The interventions under investigation include: placebo comparator (OTHER), ethosuximide (DRUG).
Who is sponsoring clinical trial NCT01122381?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.